EUVIMEDEUVIMED entdecken
Open Access

An “AND” logic gate–based supramolecular therapeutic nanoplatform for combatting drug-resistant non–small cell lung cancer

Qili Huang iD, Chendi Ding iD, Wenyan Wang iD, Li Yang iD, Yinglong Wu iD, Wenfeng Zeng, Zimu Li iD, Zhaoqing Shi iD, Lin Mei iD, Xiaowei Zeng iD, Yanli Zhao iD, Hongzhong Chen iD

Science Advances · 27.09.2024 · 10 (39)

DOI: 10.1126/sciadv.adp9071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 27.09.2024. Verfasst von Qili Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, P. R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite targeted therapies like epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), non–small cell lung cancer (NSCLC) remains a clinical challenge due to drug resistance hampering their efficacy. Here, we designed an “AND” logic gate–based supramolecular therapeutic platform (HA-BPY-GEF-NPs) for the treatment of EGFR-TKI resistant NSCLC. This system integrates both internal and external stimuli–responsive mechanisms that need to be activated in a preset sequence, enabling it to precisely control drug release behavior for enhancing therapeutic precision. By programming the system to respond to sequential near-infrared (NIR) irradiation and enzyme (cathepsin B) inputs, the release of gefitinib is effectively confined to the tumor region. Moreover, the NIR irradiation induces reactive oxygen species production, suppressing tumor growth and inhibiting bypass signaling pathways. The designed drug delivery system offers a highly controlled and targeted therapeutic approach, effectively inhibiting tumor growth, suppressing bypass signaling pathways, and overcoming EGFR-TKI resistance, thus offering a potential solution for maximizing therapeutic benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmLung NeoplasmsAntineoplastic AgentsHumansAnimalsCell Line, TumorMiceGefitinibErbB ReceptorsProtein Kinase InhibitorsDrug Delivery SystemsXenograft Model Antitumor AssaysNanoparticlesReactive Oxygen Species

Substanzen

Antineoplastic AgentsGefitinibErbB ReceptorsProtein Kinase InhibitorsReactive Oxygen Species

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, P. R. China.
  • Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical…
  • School of Chemistry, Chemical Engineering, and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.

ORCID-Profile: Qili Huang, Chendi Ding, Wenyan Wang, Li Yang, Yinglong Wu, Zimu Li, Zhaoqing Shi, Lin Mei, Xiaowei Zeng, Yanli Zhao, Hongzhong Chen

Zitieren

APA

Huang, Q., Ding, C., Wang, W., Yang, L., Wu, Y., Zeng, W., Li, Z., Shi, Z., Mei, L., Zeng, X., Zhao, Y., & Chen, H. (2024). An “AND” logic gate–based supramolecular therapeutic nanoplatform for combatting drug-resistant non–small cell lung cancer. Science Advances, 10(39). https://doi.org/10.1126/sciadv.adp9071

Vancouver

Huang Q, Ding C, Wang W, Yang L, Wu Y, Zeng W, et al. An “AND” logic gate–based supramolecular therapeutic nanoplatform for combatting drug-resistant non–small cell lung cancer. Science Advances. 2024;10(39). doi:10.1126/sciadv.adp9071

BibTeX
@article{Huang2024,
  author = {Huang, Qili and Ding, Chendi and Wang, Wenyan and Yang, Li and Wu, Yinglong and Zeng, Wenfeng and Li, Zimu and Shi, Zhaoqing and Mei, Lin and Zeng, Xiaowei and Zhao, Yanli and Chen, Hongzhong},
  title = {An “AND” logic gate–based supramolecular therapeutic nanoplatform for combatting drug-resistant non–small cell lung cancer},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {39},
  doi = {10.1126/sciadv.adp9071}
}
Kostenlos starten →